Texas HB 3922: Relating to information provided by health care providers and hospitals to certain patients regarding pharmaceutical manufacturer patient assistance programs for insulin.

Status: Referred to Health & Human Services (as of 2021-05-12)

State: Texas · Session: 87 · Bill: HB 3922

Subjects: DIABETES (S0486), HEALTH & HUMAN SERVICES COMMISSION (V0177), Health Care Providers (I0387), Health--Other Diseases & Medical Conditions (I0383), Hospitals (I0400)

Sponsors: Oliverson

View Texas HB 3922 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.